Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ardelyx

Clinical trials sponsored by Ardelyx, explained in plain language.

Ardelyx ARDX NASDAQ

Biopharmaceutical company developing treatments for gastrointestinal and kidney diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 3

New drug aims to ease chronic constipation in large trial

Symptom relief Recruiting now

This study tests three doses of tenapanor (5, 25, or 50 mg twice daily) against a placebo in 692 adults with chronic idiopathic constipation. Over 26 weeks, researchers will check if the drug increases complete spontaneous bowel movements. The goal is to find a safe, effective op…

Phase: PHASE3 • Sponsor: Ardelyx • Aim: Symptom relief

Last updated Jun 27, 2026 13:03 UTC